# Abbott Laboratories net income entity: /record/abbott-laboratories.md predicate: net_income page: /record/abbott-laboratories/net_income as_of: 2026-11-09 cite: AsOf. "Abbott Laboratories quarterly net income: 920,000,000 United States dollar", as of 2026-09-30. Claim clm_0E055280C61A, https://asof.is/claim/clm_0E055280C61A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/0001628280-26-070154-index.htm. As of November 9, 2026, the latest net income figure on the AsOf record for Abbott Laboratories is $920 million for the quarter ended September 30, 2026, from a primary source (sec.gov). Abbott Laboratories's latest full-year net income is $6.52 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 15 claims on Abbott Laboratories's net income, 1 open and 14 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest net income The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_net_income claim, kept apart from the full-year series. - [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_net_income | 920,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_0E055280C61A](/claim/clm_0E055280C61A.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/0001628280-26-070154-index.htm ## Latest full-year net income What the record asserts on 2026-11-09. - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 6,524,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_76AC317902A6](/claim/clm_76AC317902A6.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 4,728,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_E0C8ECF41AD1](/claim/clm_E0C8ECF41AD1.md) | [clm_E3BAB111231C](/claim/clm_E3BAB111231C.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746914001176/0001047469-14-001176-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 5,963,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_C538B005C944](/claim/clm_C538B005C944.md) | [clm_E0C8ECF41AD1](/claim/clm_E0C8ECF41AD1.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746914001176/0001047469-14-001176-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 2,576,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_B11F523F3F14](/claim/clm_B11F523F3F14.md) | [clm_C538B005C944](/claim/clm_C538B005C944.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746914001176/0001047469-14-001176-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 2,284,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_E00F0EE99100](/claim/clm_E00F0EE99100.md) | [clm_B11F523F3F14](/claim/clm_B11F523F3F14.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746915001377/0001047469-15-001377-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 4,423,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_87CC51296794](/claim/clm_87CC51296794.md) | [clm_E00F0EE99100](/claim/clm_E00F0EE99100.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746916010246/0001047469-16-010246-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 1,400,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_0E0A2ADD6C11](/claim/clm_0E0A2ADD6C11.md) | [clm_87CC51296794](/claim/clm_87CC51296794.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746917000744/0001047469-17-000744-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 477,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_431C6CD455C6](/claim/clm_431C6CD455C6.md) | [clm_0E0A2ADD6C11](/claim/clm_0E0A2ADD6C11.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746918000856/0001047469-18-000856-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 2,368,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_82D437604E1A](/claim/clm_82D437604E1A.md) | [clm_431C6CD455C6](/claim/clm_431C6CD455C6.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746919000624/0001047469-19-000624-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 3,687,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_492C7215F04B](/claim/clm_492C7215F04B.md) | [clm_82D437604E1A](/claim/clm_82D437604E1A.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000110465920023904/0001104659-20-023904-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 4,495,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_D4753923237F](/claim/clm_D4753923237F.md) | [clm_492C7215F04B](/claim/clm_492C7215F04B.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000110465921025751/0001104659-21-025751-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 7,071,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_11981DF05BC7](/claim/clm_11981DF05BC7.md) | [clm_D4753923237F](/claim/clm_D4753923237F.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000110465922025141/0001104659-22-025141-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 6,933,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_1E79DAD01E1C](/claim/clm_1E79DAD01E1C.md) | [clm_11981DF05BC7](/claim/clm_11981DF05BC7.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 5,723,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_CF3E98D0B268](/claim/clm_CF3E98D0B268.md) | [clm_1E79DAD01E1C](/claim/clm_1E79DAD01E1C.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 13,402,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_76AC317902A6](/claim/clm_76AC317902A6.md) | [clm_CF3E98D0B268](/claim/clm_CF3E98D0B268.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | net_income | 6,524,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_76AC317902A6](/claim/clm_76AC317902A6.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm ## What replaced what - $4.73 billion (2011-12-31 to 2012-12-31, [clm_E3BAB111231C](/claim/clm_E3BAB111231C.md)) was replaced by $5.96 billion from 2012-12-31 ([clm_E0C8ECF41AD1](/claim/clm_E0C8ECF41AD1.md)) - $5.96 billion (2012-12-31 to 2013-12-31, [clm_E0C8ECF41AD1](/claim/clm_E0C8ECF41AD1.md)) was replaced by $2.58 billion from 2013-12-31 ([clm_C538B005C944](/claim/clm_C538B005C944.md)) - $2.58 billion (2013-12-31 to 2014-12-31, [clm_C538B005C944](/claim/clm_C538B005C944.md)) was replaced by $2.28 billion from 2014-12-31 ([clm_B11F523F3F14](/claim/clm_B11F523F3F14.md)) - $2.28 billion (2014-12-31 to 2015-12-31, [clm_B11F523F3F14](/claim/clm_B11F523F3F14.md)) was replaced by $4.42 billion from 2015-12-31 ([clm_E00F0EE99100](/claim/clm_E00F0EE99100.md)) - $4.42 billion (2015-12-31 to 2016-12-31, [clm_E00F0EE99100](/claim/clm_E00F0EE99100.md)) was replaced by $1.4 billion from 2016-12-31 ([clm_87CC51296794](/claim/clm_87CC51296794.md)) - $1.4 billion (2016-12-31 to 2017-12-31, [clm_87CC51296794](/claim/clm_87CC51296794.md)) was replaced by $477 million from 2017-12-31 ([clm_0E0A2ADD6C11](/claim/clm_0E0A2ADD6C11.md)) - $477 million (2017-12-31 to 2018-12-31, [clm_0E0A2ADD6C11](/claim/clm_0E0A2ADD6C11.md)) was replaced by $2.37 billion from 2018-12-31 ([clm_431C6CD455C6](/claim/clm_431C6CD455C6.md)) - $2.37 billion (2018-12-31 to 2019-12-31, [clm_431C6CD455C6](/claim/clm_431C6CD455C6.md)) was replaced by $3.69 billion from 2019-12-31 ([clm_82D437604E1A](/claim/clm_82D437604E1A.md)) - $3.69 billion (2019-12-31 to 2020-12-31, [clm_82D437604E1A](/claim/clm_82D437604E1A.md)) was replaced by $4.5 billion from 2020-12-31 ([clm_492C7215F04B](/claim/clm_492C7215F04B.md)) - $4.5 billion (2020-12-31 to 2021-12-31, [clm_492C7215F04B](/claim/clm_492C7215F04B.md)) was replaced by $7.07 billion from 2021-12-31 ([clm_D4753923237F](/claim/clm_D4753923237F.md)) - $7.07 billion (2021-12-31 to 2022-12-31, [clm_D4753923237F](/claim/clm_D4753923237F.md)) was replaced by $6.93 billion from 2022-12-31 ([clm_11981DF05BC7](/claim/clm_11981DF05BC7.md)) - $6.93 billion (2022-12-31 to 2023-12-31, [clm_11981DF05BC7](/claim/clm_11981DF05BC7.md)) was replaced by $5.72 billion from 2023-12-31 ([clm_1E79DAD01E1C](/claim/clm_1E79DAD01E1C.md)) - $5.72 billion (2023-12-31 to 2024-12-31, [clm_1E79DAD01E1C](/claim/clm_1E79DAD01E1C.md)) was replaced by $13.4 billion from 2024-12-31 ([clm_CF3E98D0B268](/claim/clm_CF3E98D0B268.md)) - $13.4 billion (2024-12-31 to 2025-12-31, [clm_CF3E98D0B268](/claim/clm_CF3E98D0B268.md)) was replaced by $6.52 billion from 2025-12-31 ([clm_76AC317902A6](/claim/clm_76AC317902A6.md)) ## Questions this record answers ### What is Abbott Laboratories's current net income? The latest figure on the record is $920 million for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $6.52 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026. ### What was Abbott Laboratories's net income for the quarter ended September 30, 2026? $920 million for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Abbott Laboratories's net income last change? The latest value on the record is $6.52 billion, dated December 31, 2025; before it the record holds $13.4 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Abbott Laboratories's net income before $6.52 billion? $13.4 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/abbott-laboratories/net_income (markdown: /record/abbott-laboratories/net_income.md) - Entity twin: /record/abbott-laboratories.md ยท timeline: /timelines/abbott-laboratories.md - Every company's net income: /facts/net_income.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.